German Crypto Startup CeBioLabs Launches Blockchain-Based Solution for Authenticity Verification of Laboratory Analyses
Hamburg, Germany - April 13, 2023 (Investorideas.com Newswire) CeBioLabs, a German crypto startup, has launched its latest development, Lab-Authenticity.org. The Lab-Authentity.org platform is a groundbreaking blockchain-based solution that enables producers, manufacturers, and suppliers to prove the authenticity of certificates of analysis. Lab-Authenticity.org is the first Blockchain-based system in the world, that restores trust in certificates of analysis and makes them retrievable for customers and other market players.
CeBioLabs is a young German project offering Supply Chain Management in the pharmaceutical- and also Cannabis industries. CeBioLabs is coming from the blockchain technology sector. The development of the entire project concept took more than a year. The experience and respective expertise in the fields of Pharma, Cannabis and blockchain technology provide the project with huge possibilities, making it the first of its kind in the world. The German company is also preparing with its developments for the upcoming Cannabis legalization in Germany, which will open a new and huge market.
CeBioLabs has been accompanied from the beginning by a renowned German law firm for financial and capital law.
With Lab-Authenticity.org, market participants worldwide have the possibility to ensure the authenticity of the documents. The certificates of analysis are not provided by the suppliers themselves, but exclusively by laboratories, ensuring that only original documents are involved, which are stored in the blockchain. The blockchain technology makes all stored data unchangeable and transparent for all market participants, retrievable at any time. Lab-Authenticity.org supports certificates of analysis for the food, pharmaceutical, Cannabis, and chemical industries.
Lab-Authenticitiy.org is part of CeBioLabs, a German crypto startup, and the CBSL token is considered the link of all CeBioLabs projects, accepted as a means of payment on Lab-Authenticitiy.org. Thus, the project has a direct link to the CBSL token and the crypto market. In the future, players will trade in new technologies and processes that have the potential to shape and transform the future of the markets.
Christian Tonn, CEO and Founder of CeBioLabs, confirms a high demand for Lab-Authenticity.org: "In Europe, we already have a high demand from the food and pharmaceutical industry for our latest development LabAuthentity.org. We were able to win our first customers even before the launch, including a big player of the German Pharma industry. In addition, there is the upcoming legalization of cannabis in Germany and many other countries. This will not only increase the demand for cannabis, but also for solutions and systems that can control and ensure the supply chains and quality criteria of companies."
With the new developments, CeBioLabs is dedicated to addressing the key issue of proving the authenticity of certificates of analysis, which has been highlighted by the German government. The company believes that this market presents a huge opportunity and is well-positioned to provide the right solution at the right time through its LabAuthentity.org platform. Intending users visit the following links for more updates:
Contact: Christian Tonn
Company: CeBiol Blockchain Solutions GmbH
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/